Nanoparticle-based targeted delivery unleashes the full power of anti-cancer drugs

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to cancer cells and not normal cells, potentially allowing clinicians to administer higher, more effective doses of anti-cancer drugs while avoiding some of the well-known toxic side effects.